Tisdag 5 Maj | 19:41:34 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-06-04 07:00 Bokslutskommuniké 2026
2026-03-05 - Kvartalsrapport 2026-Q3
2025-11-21 - Kvartalsrapport 2026-Q2
2025-11-10 - Extra Bolagsstämma 2025
2025-10-29 - Årsstämma
2025-09-25 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2025-09-01 - Kvartalsrapport 2026-Q1
2025-06-03 - Bokslutskommuniké 2025
2025-03-03 - Kvartalsrapport 2025-Q3
2024-12-04 - Kvartalsrapport 2025-Q2
2024-09-26 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2024-09-25 - Årsstämma
2024-08-29 - Kvartalsrapport 2025-Q1
2024-05-30 - Bokslutskommuniké 2024
2024-02-29 - Kvartalsrapport 2024-Q3
2023-12-04 - Kvartalsrapport 2024-Q2
2023-10-04 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2023-09-27 - Årsstämma
2023-08-31 - Kvartalsrapport 2024-Q1
2023-06-08 - Bokslutskommuniké 2023
2023-03-01 - Kvartalsrapport 2023-Q3
2022-12-01 - Kvartalsrapport 2023-Q2
2022-10-03 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2022-09-28 - Årsstämma
2022-08-31 - Kvartalsrapport 2023-Q1
2022-06-10 - Bokslutskommuniké 2022
2022-03-02 - Kvartalsrapport 2022-Q3
2021-12-02 - Kvartalsrapport 2022-Q2
2021-09-09 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2021-09-02 - Kvartalsrapport 2022-Q1
2021-05-31 - Bokslutskommuniké 2021
2021-03-03 - Kvartalsrapport 2021-Q3
2020-12-02 - Kvartalsrapport 2021-Q2
2020-09-30 - Årsstämma
2020-09-09 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2020-08-24 - Kvartalsrapport 2021-Q1
2020-06-08 - Bokslutskommuniké 2020
2020-04-20 - Extra Bolagsstämma 2020
2020-03-02 - Kvartalsrapport 2020-Q3
2019-12-02 - Kvartalsrapport 2020-Q2
2019-09-30 - Årsstämma
2019-09-25 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2019-09-02 - Kvartalsrapport 2020-Q1
2019-06-10 - Bokslutskommuniké 2019
2019-03-04 - Kvartalsrapport 2019-Q3
2018-12-17 - Kvartalsrapport 2019-Q2
2018-09-25 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2018-09-24 - Årsstämma
2018-09-24 - Kvartalsrapport 2019-Q1
2018-06-25 - Bokslutskommuniké 2018
2018-03-26 - Kvartalsrapport 2018-Q3
2017-12-18 - Kvartalsrapport 2018-Q2
2017-09-25 - Årsstämma
2017-09-25 - Kvartalsrapport 2018-Q1
2017-06-30 - Bokslutskommuniké 2017

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Integrum är verksamt inom medicinteknik. Bolaget utvecklar system för skelettförankrade proteser baserat på det framtagna OPRA-implantatsystemet, som senare vidaresäljs till sjukhus världen över. Implantatet sätts på patientens ben med hjälp utav titanskruvar och antas förbättra livet för en stor del patienter med amputation. Bolaget grundades 1998 och har sitt huvudkontor i Mölndal.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-05-05 15:56:00

Updated hyperlink to website

Mölndal, Sweden, May 5, 2026 — Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) launches today a patient-facing website in the US. The website has been developed to better support amputees and their families ahead of choosing a prosthetic system, while also enabling Integrum to better track and direct patients to the right care unit. The website is also being prepared for launch in additional countries.

Integrum works strategically and systematically to ensure that more patients worldwide gain access to the company's innovative, bone-anchored implant system OPRA Implant System. The establishment is currently concentrated in the US, Europe, and Ukraine, where a number of Centers of Excellence have been built – clinics with surgeons who possess the specialist expertise required for implanting the prosthetic system.

Although the infrastructure is now in place to perform many operations, it remains a challenge to reach all the amputees who would benefit from replacing their socket prostheses with bone-anchored prostheses from Integrum. To better reach and support these individuals, Integrum has developed a patient-facing, easy to navigate website. On the website, amputees and their families can find comprehensive information about OPRA Implant System and be directed to care units that can take the process forward. The website is also connected to Integrum’s internal systems, enabling the company to more efficiently track the flow of potential new users of OPRA Implant System.

"This patient-facing website is critical for us to accelerate the commercialization of OPRA Implant System. Today, we rely too heavily on healthcare providers independently identifying amputees who are unhappy with their socket prostheses and letting them know that alternatives exist. But we are confident that there are significantly more people out there who will consider switching to bone-anchored implants once they understand the benefits – and that we can do a better job of reaching them. At the same time, this is a big decision for the individual, and we need to approach that with respect, providing plenty of information and support throughout the entire process. We are now able to do this in a whole new way, and I look forward to seeing the US organization's new approach in action – and then rolling this website out to more markets," comments Martin Hillsten, CEO of Integrum.

The new website can be found at opraimplantsystem.com

Read an extended comment from CEO Martin Hillsten and an interview with project manager Johan Pfannenstill at Integrum Investor News: investors.integrum.se